Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
New England Journal of Medicine · 31.08.2023 · 389 (9) · 808-819
DOI: 10.1056/nejmoa2301496 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift New England Journal of Medicine, erschienen am 31.08.2023. Verfasst von Tingdong Li und 24 weiteren Autor:innen. Beteiligte Einrichtung: From the State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, …. Hauptthemen laut MEDLINE: Antibodies, Viral, Early Detection of Cancer, Herpesvirus 4, Human, Nasopharyngeal Carcinoma. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fujian Provincial Department of Science and Technology, Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the State Key Laboratory of Vaccines for Infectious Diseases, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutic…
ORCID-Profile: Tingdong Li, Honglin Chen
Förderung
- Fujian Provincial Department of Science and Technology
- Ministry of Education of the People's Republic of China
- Ministry of Science and Technology of the People's Republic of China
- Ministry of Education of the People’s Republic of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Li, T., Li, F., Guo, X., Hong, C., Yu, X., Wu, B., Lian, S., Song, L., Tang, J., Wen, S., Gao, K., Hao, M., Cheng, W., Su, Y., Zhang, S., Huang, S., Fang, M., Wang, Y., Ng, M. H., …, & Ji, M. (2023). Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer. New England Journal of Medicine, 389(9), 808-819. https://doi.org/10.1056/nejmoa2301496
Vancouver
Li T, Li F, Guo X, Hong C, Yu X, Wu B, et al. Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer. New England Journal of Medicine. 2023;389(9):808-819. doi:10.1056/nejmoa2301496
BibTeX
@article{Li2023,
author = {Li, Tingdong and Li, Fugui and Guo, Xiaoyi and Hong, Congming and Yu, Xia and Wu, Biaohua and Lian, Shifeng and Song, Liuwei and Tang, Jiabao and Wen, Shunhua and Gao, Kaimin and Hao, Mengling and Cheng, Weimin and Su, Yingying and Zhang, Shiyin and Huang, Shoujie and Fang, Mujin and Wang, Yingbin and Ng, Mun-Hon and Chen, Honglin and Luo, Wenxin and Ge, Shengxiang and Zhang, Jun and Xia, Ningshao and Ji, Mingfang},
title = {Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {9},
pages = {808--819},
doi = {10.1056/nejmoa2301496}
}
EUVIMED